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Abstract
The stimulation of adult hippocampal neurogenesis by antidepressants has been associated with multiple molecular
pathways, but the potential influence exerted by other brain areas has received much less attention. The basolateral
complex of the amygdala (BLA), a region involved in anxiety and a site of action of antidepressants, has been implicated in
both basal and stress-induced changes in neural plasticity in the dentate gyrus. We investigated here whether the BLA
modulates the effects of the SSRI antidepressant fluoxetine on hippocampal cell proliferation and survival in relation to a
behavioral index of depression-like behavior (forced swim test). We used a lesion approach targeting the BLA along with a
chronic treatment with fluoxetine, and monitored basal anxiety levels given the important role of this behavioral trait in the
progress of depression. Chronic fluoxetine treatment had a positive effect on hippocampal cell survival only when the BLA
was lesioned. Anxiety was related to hippocampal cell survival in opposite ways in sham- and BLA-lesioned animals (i.e.,
negatively in sham- and positively in BLA-lesioned animals). Both BLA lesions and low anxiety were critical factors to enable
a negative relationship between cell proliferation and depression-like behavior. Therefore, our study highlights a role for the
amygdala on fluoxetine-stimulated cell survival and on the establishment of a link between cell proliferation and
depression-like behavior. It also reveals an important modulatory role for anxiety on cell proliferation involving both BLA-
dependent and –independent mechanisms. Our findings underscore the amygdala as a potential target to modulate
antidepressants’ action in hippocampal neurogenesis and in their link to depression-like behaviors.
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Introduction
The enhancement of adult hippocampal neurogenesis induced
by a wide variety of antidepressant treatments has attracted a great
deal of attention [1,2,3]. In rodents, chronic antidepressant
administration has been shown to increase both the proliferation
of neural progenitors in the subgranular zone of the dentate gyrus
(DG) [4] and the survival of these newborn neurons [5]. Intensive
research is devoted to unravel the neurobiological mechanisms
involved in the effects of antidepressants [6,7], and to disentangle
how antidepressant effects on depression-like behavior may be
mediated by hippocampal neurogenesis [8,9]. The search for
mechanisms of action has mostly focused on the involvement of
molecular pathways, including the activation of specific serotonin
receptors [9,10,11], the cAMP-CREB signaling pathway [12], and
neurotrophins, particularly brain-derived neurotrophic factor
(BDNF), fibroblast growth factor (FGF-2) and vascular endothelial
growth factor (VEGF) [13]. Although less explored, network
activity also seems to be critical for the neurogenic effects of
antidepressants [3]. Local hippocampal activity has been shown to
affect adult hippocampal neurogenesis at different phases, from
cell proliferation to cell maturation and integration [14,15,16].
However, the possibility that antidepressant effects on adult
hippocampal neurogenesis are influenced by the concerted action
of other brain regions has not been, to our knowledge, as yet
explored.
The amygdala appears to be an excellent candidate to modulate
antidepressant-related hippocampal neurogenesis. Substantial
evidence indicates that the amygdala is a site of action of
antidepressants [17,18,19,20,21,22]. Selective serotonin reuptake
inhibitors (SSRI) antidepressant treatment was shown to modulate
amygdala responses directly in humans without requiring a clinical
change in mood or initial amygdala pathology, while diminishing
the perception of fear [23,24]. In depressed subjects, decreased
amygdala volume [25] and increased amygdala response to
masked emotional faces [26,27] were normalized after chronic
antidepressant (in particular, SSRI) treatment. In rodents, SSRI
treatment resulted in reduced levels of fear conditioning, which
depends critically on amygdala function [28]. In addition to its
well known role in the mediation of emotions [29,30], the
amygdala [particularly its basolateral division (BLA)] has been
critically implicated in the emotional potentiation of memory by
facilitating information processing and storage in other structures,
notably the hippocampus [31,32,33]. Moreover, activation of
the BLA was shown to regulate neural plasticity in the DG [34,35],
the former being also associated with stress-induced deficits in
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rats [36,37]. Furthermore, animal studies have also shown that
acute electrical stimulation of the amygdala (i.e., kindling)
increases hippocampal neurogenesis [38,39,40,41].
Here, we investigated whether the amygdala and anxiety
contribute to the effects of antidepressants on hippocampal cell
proliferation and survival, and on a behavioral index of
depression-like behavior (the forced swim test). We used a lesion
approach targeting the basolateral amygdala together with a
chronic treatment with the SSRI antidepressant fluoxetine.
Anxiety (as indexed by animal’s anxiety levels before the onset
of antidepressant treatment) was included in the analyses given its
important modulatory role in both vulnerability and recovery from
depression [42]. Moreover, given the interest for understanding
how indices of both cell proliferation and survival, as well as of
depression-like behavior relate to each other [3,8,9,43], the
relationship between these factors was also explored. We applied
parametric statistics followed by structural equation modeling
(SEM) to test for unique and shared variance of the factors on
depression-like behavior, as well as to assess how cell proliferation
and survival are engaged by the interacting effects of fluoxetine,
BLA lesions, and anxiety, in relation to the selected index of
depressive-like behavior.
Materials and Methods
Subjects
Adult male Sprague-Dawley rats (Charles River Laboratories,
France) were used (250–275 g of body weight at the beginning of
the experiment, approximately three months old). Rats were
housed two per cage and maintained with ad libitum access to food
under light (12 hours light/dark cycle; lights on at 7:00 AM) and
temperature (2262uC) controlled conditions. Experimental pro-
cedures were approved by the Cantonal Veterinary Authorities
(Vaud, Switzerland).
General Experimental Procedures
Rats were submitted to stereotaxic surgery for Sham (n=38) or
BLA lesions (n=43). After recovery from surgery (11 days), rats
were handled again for 3 days and tested in the elevated plus-maze
(EPM) to determine individual anxiety levels. Three days after
testing in the EPM, Sham and BLA lesion groups were each divided
into two subgroups that were matched according to anxiety levels
and body weight, and assigned to the drug treatment ‘vehicle’ or
‘fluoxetine’. Therefore, the study comprised four groups: Sham
lesion/Vehicle (Sh/Vh), Sham lesion/Fluoxetine (Sh/Flx), BLA
lesion/Vehicle (BLA/Vh), and BLA lesion/Fluoxetine (BLA/Flx).
Fluoxetine treatment was given daily during 5 weeks. Since the
number of animals in each group was corrected after histological
verification of the extent of the lesions, the sample size for each
group differed from the initial group size and is reported in the
corresponding Results section. Bromodeoxyuridine (BrdU) injec-
tions to evaluate survival of proliferating cells were given on days 21
and 22 of fluoxetine treatment. One day after the end of fluoxetine
treatment, rats were tested in the forced-swim test and sacrificed
15 min after the test (see Figure 1).
Elevated Plus Maze
Anxiety levels were evaluated using the EPM test [44]. Briefly,
the test consists of two opposing open arms (45610 cm)
perpendicular to two enclosed arms (45610650 cm) that extend
from a central platform (10610 cm), elevated 65 cm above the
floor. The rats were placed individually on the central platform
and allowed to explore the maze for five minutes. Their behavior
was monitored using a video camera and analyzed with a
computerized tracking system (Ethovision 3.1.16, Noldus IT, The
Netherlands). The time spent in the open and closed arms,
distance moved and transitions between the different arms were
recorded.
Surgery
Rats were anesthetized using an intraperitoneal injection of a
combination of 75 mg/kg of ketamine chlorhydrate (2-(2-chlorophe ´-
nyl)-2-me ´thylamino-cyclohexan-1-one; Graeub, Bern, Switzerland)
and 10 mg/kg of xylazine chlorhydrate (N-(2,6-dimethylphenyl)-5,6-
dihydro-4H-1,3-thiazin-2-amine; Graeub, Bern, Switzerland). Rats
were then placed into a stereotaxic apparatus (Stoelting, USA), the
scalp was incised and retracted, the head position was adjusted to
place Bregma and Lambda in the same horizontal plane and small
burr holes were drilled in the skull above the basolateral complex of
the amygdala to accommodate a 28 gauge infusion cannula (2.5 mm
posterior to bregma, +/2 4.5 mm lateral to bregma, 8.2 mm ventral
to the skull surface). A 10 ml Hamilton syringe mounted on an
infusion pump (Harvard Apparatus, South Natick, MA) and
connected to the cannula with polyethylene tubing was used to
deliver infusions. BLA lesions were made by injecting bilaterally
0.4 ml of NMDA (N-methyl-D-aspartic acid) (20 mg/ml; Sigma, St.
Louis, MO) in 100 mM PBS, pH 7.4, at a rate of 0.2 ml/min. Sham
lesion rats underwent an identical procedure, except that the cannula
was filled with vehicle, lowered and no infusions were made [45].
After surgery, animals were returned to their home cages and allowed
11 days of recovery followed by three days of handling before
behavioral testing.
Chronic fluoxetine treatment
Fluoxetine hydrochloride ((7)-N-methyl-g-(4-[trifluoromethyl]-
phenoxy)-benzenepropanamine) (Mepha, Aesch, Switzerland) was
administered daily during 35 days in the rats’ tap water (10 mg/kg)
Figure 1. Schematic plan of experimental procedures and timetable. After handling (H), rats were submitted to stereotaxic surgery for BLA
or sham lesions. After recovery, animals were handled again and levels of anxiety were characterized using the Elevated Plus Maze (EPM). Next,
chronic fluoxetine treatment was initiated and BrdU was injected after twenty one days of drug administration. After interruption of fluoxetine
treatment, depression-like behavior was evaluated using the Forced Swim Test (FST) and then sacrificed.
doi:10.1371/journal.pone.0008618.g001
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recorded regularly. The drug concentration was adjusted according
to changes in water intake and body weight in order to reach the
target dose of 10 mg/kg across the experiment. Vehicle groups
received tap water during the same period. In order to control for
water intake and thus fluoxetine dosage, a Plexiglas separator
allowing visual and olfactory contact divided each housing cage into
two parts.
BrdU injections
Rats were injected with the thymidine analog bromodeoxyur-
idine (BrdU; 50 mg/kg, i.p.) (Sigma-Aldrich, St Louis, MO, USA)
dissolved in a phosphate buffer (0.1 M, pH 8.4). Four injections
were made, one every 12 hours over a period of two days, starting
on day 21 of fluoxetine treatment [46].
Forced-swim Test
One day after the last fluoxetine treatment, rats were submitted
to a forced-swim test to evaluate depression-like behaviors [47,48].
Briefly, they were individually placed in a plastic beaker (25 cm
diameter, 46 cm deep) containing 30 cm of water (2561uC) for 5
minutes. Even though this test is conventionally performed in two
sessions, 24 hours apart, during which time spent in immobility is
scored [49], we only performed one testing session. The reasons
for applying a single forced swim session are the following: (i) The
standard forced swimming test was developed for its sensitivity
to evince behavioral effects of wide range of clinically active
antidepressant drugs that, when injected on day 1 result in reduced
immobility on the test performed on day 2 [49]. However, when
the test has been used to assess whether chronic stress can affect
behavioral ‘‘despair’’ and, hence, depression-like behavior, a single
session has proven sensitive to evidence increased behavioral
immobility in depressed animals [50,51]. (ii) The second important
reason not to extend the protocol to a second forced swim test
taking place on a subsequent day was related to the main goal of
the study, aiming to compare the impact of different factors
(notably, amygdala lesions and fluoxetine treatment) on hippo-
campal cell proliferation. Since hippocampal cell proliferation
and/or survival have been shown to be affected by prior stress
[52,53], we reasoned that sacrificing animals immediately after a
single stress session (forced swim) would not allow sufficient time
for the stress-induced changes in cell proliferation to evolve.
Behavior was recorded with a video camera and the time spent
immobile (making only those movements necessary to keep the
snout above the water), swimming, climbing or diving was
quantified manually using a computer program (The Observer
5.0.25, Noldus IT, 2003).
Histological procedures
Fifteen minutes after the end of the forced-swim test, animals
were anesthetized with isofluorane and transcardially perfused
using 0.9% saline solution followed by a fixative solution of
paraformaldehyde 4% in phosphate buffered saline (PBS,
pH=7.5). After perfusion-fixation, brains were removed and
post-fixed in the same solution for four hours. Next, 50 mm
coronal sections were cut on a vibratome (VT 1000S; Leica,
Glattbrugg, Switzerland) and stored in 4uC PBS. Cell proliferation
in the dentate gyrus was measured by assaying the expression of
the endogenous marker, Ki67. Survival of proliferating cells was
assayed by staining for BrdU.
Alternate series of 1 in 10 sections were processed ‘‘free-
floating’’ for immunohistochemical visualization of newborn
neurons (Ki67) and mature neurons (NeuN), the latter helping
determine the extent of the lesions. Briefly, sections were
incubated with 3% H2O2 in PBS for 10 minutes to block
endogenous peroxidase activity. After washing in PBS (3610
minutes), the sections were treated for 1 hour with 5% normal
donkey serum (NDS, Jackson ImmunoResearch Laboratories,
West Grove, PA) in PBS with 0.2% Triton-X100 (Sigma-Aldrich,
St. Louis, MO). After washing in PBS, they were incubated
overnight at room temperature with monoclonal mouse anti-Ki67
antibody (1:200; Novocastra) or monoclonal mouse anti-NeuN
biotinylated antibody (1:200, Chemicon). PBS containing 0.2%
Triton-X100 and 3% NDS (PBST) was used for primary and
secondary antibodies dilution. After washing in PBS, sections for
Ki67 were incubated for 120 minutes with donkey anti-mouse
IgG, (1:250; Jackson ImmunoResearch Laboratories). Sections for
NeuN did not require secondary antibody because the antibody
used was biotinylated. After washing in PBS, sections were
incubated during one hour with avidin-biotin-peroxidase complex
(ABC; A 1:200, B 1:200; Vector Laboratories, Peterborough,
UK), prepared 30 minutes before in PBS. And after washing in
PBS, color development was achieved by incubating with 3,39
diaminobenzidine tetrahydrochloride (DAB; 0.5 mg/ml Sigma-
Aldrich) for 15 minutes.
For BrdU immunohistochemistry, a previous step of denatur-
ation was performed: after blockade of the endogenous peroxidase,
sections were incubated for 1 hour at 60uC, treated with 2 N HCl
(30 min at 37uC) and then rinsed in borate buffer during 5 min
(0.1 M; pH 8.4). After washing in PBS (3610 minutes), the
sections were treated for 1 hour with 5% normal donkey serum
(NDS, Jackson ImmunoResearch Laboratories, West Grove, PA)
in PBS with 0.2% Triton-X100 (Sigma-Aldrich, St. Louis, MO).
After washing in PBS, they were incubated overnight at room
temperature with a mouse monoclonal anti-BrdU antibody (1:500,
Oxford). Following washes in PBS, sections were incubated for 120
minutes with donkey anti-rat IgG biotinilated antibody. Sections
were processed in parallel, and immunoreactivities were visualized
by the biotin–streptavidin technique (ABC kit; Vector Laborato-
ries, Peterborough, UK) using 3,3-diaminobenzidine as chromo-
gen (DAB; 0.5 mg/ml Sigma-Aldrich) [54].
Image analysis
The total number of both Ki67 immunoreactive (IR) and BrdU-
IR cells in the dentate gyrus was estimated using a modified
version of the optical fractionator method on a systematic random
sampling of every tenth section along the rostrocaudal axis of the
hippocampal formation. Cell somata were identified and counted
in both hemispheres, with a 40X objective using an Olympus
BX51 light microscope linked to a computer. Cells appearing
above and below the focal plane were omitted to prevent counting
cell caps [54,55].
The extent of the BLA lesions was measured through images
from NeuN stained serial sections. The border of the amygdala
delineating the BLA and the border of the lesion were manually
traced and the area determined with Scion Image software
(available on the web at http://www.scioncorp.com). Measure-
ments were taken bilaterally along the entire rostrocaudal axis of
the BLA (6–9 sections for each brain) and the final values represent
the left–right average [56,57].
Statistical analyses
The SPSS 13.0 and Amos 17.0 (SPSS, Chicago, IL) statistical
packages were used for the statistical analyses. Normality and
homogeneity of variance was tested and adjusted statistics were
used as required.
Factorial analyses: Factorial analyses were applied to characterize
animals according to their anxiety-like behaviors from the EPM. A
Amygdala and Neurogenesis
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principal components as extraction method and varimax rotation
with Kaiser normalization rotation [58]. Individual factor scores
were calculated for each subject through the relative weight and
orientation (eigenvalues) of the parameters loading on the factor.
Scores were generated using a Z distribution, where the value 0
corresponds to the mean, and values are expressed in terms of
standard deviations. In addition, one of the SEM models
performed was addressed to investigate differences due to extremes
in anxiety values, which led us to classify animals in either low (LA)
or highly (HA) anxious. Thus, a categorical dichotomous score was
obtained by classifying subjects into groups of LA and HA, using
the extreme lower and higher values of the continuous scores
obtained from the factor analysis; subjects with scores within
60.25 standard deviations from the mean were excluded from this
classification.
Parametric statistics: The effect of BLA lesions on anxiety levels in
the EPM were analyzed with a Student’s t-test for independent
samples. For the analyses of the impact of BLA lesions and anxiety
on fluoxetine effects on indices of neurogenesis and depression-like
behavior, there was the constraint that anxiety was affected by
BLA lesions, and therefore it cannot be treated as an independent
variable. Hence, instead of a three-way ANOVA, sequential two-
way ANOVAs were used followed by simple effects analyses where
appropriate. Analyses were performed according to a 262 design.
Since anxiety levels can be affected by BLA lesions [59], the
relative contribution of lesion and anxiety on the behavioral and
neurogenic effects of fluoxetine, cannot be addressed with
ANOVAs. Therefore, we applied structural equation modeling
(SEM) as a more flexible alternative statistical technique to achieve
the stated aims of the current study.
Structural equation modeling (SEM): As a powerful extension of
multiple regression analyses, SEM goes beyond bivariate correla-
tions, to allow simultaneous tests of the contribution of multiple
variables (numerical and categorical), both direct and indirect, and
to establish their individual predictive ability over one or more
dependent variables. Data were first examined to determine the
suitability for multivariate analyses. The SEM analyses were based
on the maximum likelihood estimation (MLE) and the following
three indices of fit were used to test the ability of the proposed
models to provide a plausible representation of the underlying
variance structure of the data. In addition to a nonsignificant chi
square (x
2), allowing a rejection of the null hypothesis (i.e. an
unacceptable representation of the data), a good-fitting model was
considered to have a comparative fit index (CFI) $0.95 and a root
mean square approximation of variance (RMSEA) significantly
smaller than 0.05 [60,61].
In the figures for each of the proposed models, standardized beta
weights along an arrow path indicate the ability of one variable to
predict a dependent variable, ranging in absolute value from zero to
one, and each with its statistical significance (p,0.05). The optimal
model for each condition, including the path strengths between the
tested variables were determined by first testing separately either
level of each condition (lesion, drug treatment and anxiety level).
Subsequently, a multi-group (‘‘stacking’’) approach was used to
statistically compare model fit and path strengths between the
groups. Here, an ‘inclusive’ model was tested, thus combining into
one model effective paths from both levels of each condition. Next,
each path was individually constrained to test for selective
differences between the levels of each condition, e.g. [62]. Multi-
group comparison statistics for stacked models specify the statistical
significance of x
2 differences (Dx
2) when constrained and
unconstrained models are compared. Using this approach,
significant results indicate a meaningful difference in the strength
of the path(s) tested between the groups (regardless of individual
path statistical significance in either group). Furthermore, the
squared multiple correlation (R
2 or coefficient of determination),
representing a measure of the proportion of the variance of the
dependentvariablethat isexplainedbytheindependent variables,is
also presented.
Results
Verification of BLA lesions
The extent of the lesions for the rats included in the study is
shown in Figure S1. Seventeen rats (out of the initial 43 lesioned
rats) presenting an average lesion area smaller than 40% (criteria
for exclusion) of the total BLA area were eliminated from the
analyses of the study, which rendered an n=26 in the BLA lesion
group. As a consequence, the number of animals included in each
experimental group was as follows: Sh/Vh (n=17), Sh/Flx
(n=21), BLA/Vh (n=12) and BLA/Flx (n=14). As indicated in
Figure S1, the minimum extent of the lesions always included at
least 40% of the BLA while in a small percentage of cases the
maximal lesion extension occupied adjacent medial and basal
areas.
Effects of BLA lesions on anxiety levels
A factor analysis applied to the behavioral parameters extracted
from the EPM identified two main factors representing ‘anxiety’
and ‘locomotion’, with a value for each subject (Table S1). BLA
lesions induced a significant reduction of anxiety levels as
compared to sham treatment (p,0.01; Figure S2).
Effects of BLA lesions and fluoxetine treatment on cell
proliferation and survival and on depression-like
behavior
Independent two-way ANOVAs (BLA lesion and fluoxetine
treatment as factors) were performed on indices of cell prolifer-
ation and survival and on the measure of depression-like behavior.
A first ANOVA on cell proliferation data as indicated by the
number of Ki67-IR cells in the DG, revealed a significant increase
in Ki67-IR cells with fluoxetine (p,0.01), but no effect of BLA
lesions (n.s.), and no significant interaction between the two factors
(n.s.) (see section A in Figure 2). ANOVA on cell survival data as
indicated by the number of BrdU-IR cells showed a significant
interaction between lesion and drug treatment (p,0.05) (see
section B in Figure 2), a simple effects analysis confirmed that
fluoxetine treatment increased cell survival only in BLA lesioned
rats (p,0.01).
ANOVA on the immobility time in the forced-swim test
indicated a significant reduction with both lesion (p,0.01) and
fluoxetine treatment (p,0.01), but no significant interaction (n.s.)
(see section C in Figure 2).
Effects of anxiety and fluoxetine treatment on cell
proliferation and survival and on depression-like
behavior
In order to study the impact of anxiety as a dichotomized
variable, we classified subjects into groups of low (LA) and high
(HA) anxiety by selecting those animals whose punctuation in the
anxiety factor was 0.25 standard deviations either above (HA;
n=28; 19 sham y 9 lesion) or below (LA; n=24; 11 sham and 13
lesion) the mean. Mean comparison confirmed that these two
groups differed significantly on the anxiety factor (Student-t test;
p,0.01; Figure S3). Then, independent two-way ANOVAs
(anxiety levels and fluoxetine treatment as factors) were performed
Amygdala and Neurogenesis
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behavior. Although ANOVAs performed respectively on Ki67-
(see section D in Figure 2) and BrdU-IR (see section E in Figure 2)
cell number indicated a lack of effect of anxiety on either of these
indices of neurogenesis (all n.s.), a significant facilitating effect of
fluoxetine treatment (all p,0.5) was observed. No significant
interaction between these two factors was seen in either case.
Analysis of the behavioral outcome (see section F in Figure 2)
indicated that high anxiety was significantly associated with
prolonged immobility in the forced-swim test (p,0.05). While
there was no effect of fluoxetine (n.s.), there was a significant
interaction between the two factors (p,0.05), and a simple effects
analysis confirmed that fluoxetine decreased immobility time only
in the HA group (p,0.01).
Correlational analyses between indices of anxiety, cell
proliferation and survival and depression-like behavior
We then performed correlational analyses to address the
following key questions: (i) whether differences in anxiety levels
play a role in the studied effects, and (ii) whether there is a
relationship between indices of neurogenesis and depression-like
behavior. The analyses were performed on data from all animals
in the study and then separately for each experimental group (see
correlational matrix in the Table S2). Anxiety levels showed
significant positive correlations with immobility in the forced-swim
test both for the whole sample (r=0.30, p,0.05) and for the
BLA/Vh group (r=0.79, p,0.01). Meanwhile negative correla-
tions with Ki67-IR cell number were found in the same, BLA/Vh
group (r=20.77, p,0.01) and with BrdU-IR cells in the Sh/Vh
group (r=20.75, p,0.01). Exclusively for BLA/Vh animals was
the immobility time in the forced-swim test negatively correlated
with the levels of Ki67-IR cells (r=20.67; p,0.01) and positively
correlated with the levels of cell BrdU-IR cells (r=0.75; p,0.05).
For the other experimental groups, no significant correlations were
observed.
Structural equation modeling
Construction of the models was guided by the results from
the ANOVAs and the correlational matrix (see above) on the
relationships between the six studied variables (fluoxetine treat-
ment, BLA lesion, anxiety levels, Ki67, BrdU, and FST
immobility). Details for total and indirect effects and path strength
differences for the presented models are shown in Tables S3 to S9.
In the text, below, only significant relationships (and occasionally
nearly significant trends) are indicated.
A general model (Figure 3) was generated in which a relational
structure between the variables was proposed to test the direct or
indirect impact of each of the 3 predictor variables (fluoxetine
treatment, BLA lesion, anxiety levels) on the 3 output measures
(Ki67, BrdU, and FST immobility) and in turn of the neurogenic
Figure 2. Effects of chronic treatment with fluoxetine on levels of cell proliferation and survival in the dentate gyrus of the
hippocampus and depression-like behavior during the forced swimming test after neurochemical lesions of the basolateral
complex of the amygdala (A,B,C) and according to anxiety (D,E,F). Error bars represent the standard error of the mean. [**p,0.01, *p,0.05
vs. corresponding vehicle group (ANOVA main effect); ++p,0.01, +p,0.05 vs. corresponding vehicle group (ANOVA simple main effect).
doi:10.1371/journal.pone.0008618.g002
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ria established, this is a good-fitting model (x
2=1.21, df=2,
p=0.751; CFI=1.00; RMSEA ,0.01, p=0.792, see Table S3 for
total and indirect effects). As frequently reported in the literature,
in this model including all animals and experimental conditions,
we confirm similar positive effects of fluoxetine treatment on levels
of both Ki67-IR cells and BrdU-IR cells, as well as a negative
effect of fluoxetine on immobility time in the FST. We also
observed that BLA lesions reduced anxiety levels and immobility
time in the FST, while increasing the expression of BrdU-IR cells
specifically. Anxiety levels were negatively related to levels of
Ki67-IR cells, while the latter variable was in turn again negatively
related to immobility time in the FST.
Next, this general model was the basis to further assess whether
the established relationships within the overall structure differed
for each of the levels comprised in each of the three predicting
variables (fluoxetine treatment, BLA lesion, anxiety levels). As a
first step, three independent models were derived by excluding, in
each case, one of the predicting variables. For each case, a good
fitting model was obtained for at least one level (Figures 4–6), thus
enabling multi-group stacked model analyses in order to directly
compare both levels of the variable in question. Thus, specific path
strength differences between the two levels of each variable could
be statistically compared.
Path analyses for the modulatory role of BLA lesions: To assess the
potential modulation of BLA lesions over the neurogenic and
behavioral actions of fluoxetine, a stacked, multi-sample analysis
was used to compare Sham and BLA lesion groups (Figure 4).
Importantly, stacked group analyses revealed an overall difference
in the model fit between the sham and the BLA lesion groups
(p,0.002, Table S4). This analysis also confirmed the existence of
significant differences between Sham and BLA lesioned groups, as
exhibited by the beta weights shown in Figure 4, specifically in
three pathways: (i) the effect of fluoxetine treatment on BrdU-IR
cells, reflecting the fact that in the BLA lesion condition, fluoxetine
treatment was related to higher levels of BrdU-IR cells, a
relationship that was absent in the sham lesion condition; (ii) the
relation between anxiety and BrdU-IR cells: whereas anxiety
predicted lower levels of BrdU-IR cells in the sham lesion
condition, an opposite pattern was observed for BLA lesioned
animals; (iii) the relationship between Ki67 levels and immobility
in the FST, with this relationship been negative for BLA lesioned
animals but inexistent in the sham group.
In addition, it may be worth noting other pathways in which
differences among the two groups approached significance. In all
the following cases a relationship present in the BLA lesion group
was notably weaker, if not absent, than in the intact BLA group: (i)
a negative influence of fluoxetine in FST immobility; (ii) a positive
relationship of BrdU on FST immobility; and (iii) a negative
influence of anxiety in Ki67. Furthermore, as the beta weights
show in Figure 4, specifically in the BLA lesion group, anxiety
Figure 3. Path analysis and fit test for the general model
(x
2=1.21, df=2, p=0.751; CFI=1.00; RMSEA,0.01, p=0.792).
Significant paths (*p,0.05; **p,0.01) are in black and non significant in
gray. The squared multiple correlations (R
2) of the endogenous
variables are located in their right inferior corner in gray and italics.
doi:10.1371/journal.pone.0008618.g003
Figure 4. Path analysis for the models according to the lesion groups. A. Model fit was tested separately for the sham lesion group
(x
2=5.42, df=2, p=0.066; CFI=0.48; RMSEA=0.21, p=0.083) and B. for the BLA lesion group (x
2=0.52, df=2, p=0.771; CFI=1.00; RMSEA,0.01,
p=0.783). Significant paths (p,0.05; **p,0.01) are in black and non significant in gray. The squared multiple correlations (R
2) of the endogenous
variables are located in their right inferior corner in gray and italics.
doi:10.1371/journal.pone.0008618.g004
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regulation of Ki67 and BrdU (total and indirect effect breakdown,
see Table S5). This BLA lesion model exhibited particularly high
predictive power (R
2 values in Fig. 4B). The joint contribution of
anxiety and fluoxetine accounted for 51% of the variance of BrdU
levels; and fluoxetine with anxiety, the latter indirectly through
both measures of neurogenic activity (Ki67 and BrdU), also in turn
successfully accounted for an important proportion of the variance
of the immobility measure (58%).
Path analyses for the modulatory role of anxiety: In order to test the
potential modulatory role of anxiety levels over the neurogenic
and behavioral actions of fluoxetine, a multiple-sample analysis
was generated for the low and high anxiety groups. In this case,
because most BLA lesioned subjects also exhibited low anxiety,
thus yielding uneven groups precluding formal statistical compar-
isons, the BLA factor was excluded. The resulting model revealed
a significant overall difference in model fit between low and high
anxiety groups (Figure 5; p,0.01, Table S6). A main significant
difference between the anxiety groups was the influence of Ki67
on FST immobility, which exhibited a strong negative relationship
in the LA group, while being absent in the HA group.
Additionally, in spite of their weak strength, the opposite
relationships between BrdU and FST immobility was also
significant. It is finally worth noting the path from fluoxetine to
FST immobility was negative in HA animals but absent in the LA
group, a difference that approached significance (Table S6). For
total and indirect effects see Table S7.
A final stacked multi-sample model (Figure 6; Table S8) was
considered next to complement the above findings, specifically
addressing differences due to the drug treatment. There was an
overall difference in the model fit between vehicle and fluoxetine
treated groups (p,0.05). A main difference between the drug
Figure 5. Path analysis for the models according to the anxiety groups. A. Model fit was tested separately for the low anxiety group
(x
2=0.26, df=1, p=0.611; CFI=1.00; RMSEA,0.01, p=0.621) and B. for the high anxiety group (x
2=0.01, df=1, p=0.924; CFI=1.00; RMSEA,0.01,
p=0.927). Significant paths (p,0.05; **p,0.01) are in black and non significant in gray. The squared multiple correlations (R
2) of the endogenous
variables are located in their right inferior corner in gray and italics.
doi:10.1371/journal.pone.0008618.g005
Figure 6. Path analysis for the models according to the drug treatment groups. A. Model fit was tested separately for the vehicle group
(x
2=0.07, df=1, p=0.784; CFI=1.00; RMSEA,0.01, p=0.791) and B. for the fluoxetine group (x
2=2.00, df=1, p=0.157; CFI=0.94; RMSEA=0.17,
p=0.175). Significant paths (p,0.05; **p,0.01) are in black and non significant in gray. The squared multiple correlations (R
2) of the endogenous
variables are located in their right inferior corner in gray and italics.
doi:10.1371/journal.pone.0008618.g006
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fluoxetine reduced the relationship from anxiety to FST immobility
(p,0.05). Additionally, an increase in the negative relationship of
BLA lesion to FST immobility approached significance (p=0.066).
Finally, as the beta weights show in Figure 6, specifically in the
Vehicle group, the BLA lesion indirectly increased Ki67 levels by
down-regulating anxiety (Table S9).
Overall, in addition to the confirmation of the result obtained
with the univariate analyses that fluoxetine treatment had a
positive effect on BrdU-IR only when the BLA was lesioned, the
main findings of the path analyses, that could not have been
predicted from the univariate analyses, are the revelation that i)
anxiety was critically related to BrdU levels, and this relationship
varied with the lesion condition, being negative in sham animals
and positive in BLA lesioned ones; and (ii) BLA lesions and low
anxiety were critical factors to facilitate a negative relationship
between cell proliferation and depression-like behavior.
Discussion
Our goal here was to investigate whether the amygdala plays a
keyrole onfluoxetine modulation oftheproliferation andsurvivalof
progenitor cells in the dentate gyrus of the adult hippocampus, and
on its impact on an index of depression-like behavior. A lesion
approach was applied to specifically study the contribution of the
BLA. Since BLA lesions affected animals’ anxiety, and emerging
evidence indicates that anxiety trait is linked to hippocampal
neurogenesis [43,51,63], structural equation modeling (SEM) was
applied to assess the relative contribution of both BLA lesions and
anxiety on fluoxetine effects. In addition, we explored the rela-
tionship of indices of cell proliferation and survival to the selected
index ofdepression-likebehavior(i.e., immobilityintheforcedswim
test).
We found evidence in sham-lesioned rats of a facilitating effect
of chronic fluoxetine on cell proliferation, but not on cell survival,
as recently reported in adult male rats [64]. The increase in cell
proliferation [4,65,66] but see and lack of effect on cell survival
[67,68] are in agreement with previous findings in the literature.
See [69] for negative effects on cell proliferation and [4] for
positive effects on cell survival.
Both parametric statistics and SEM confirmed a key role for
BLA lesions in enabling a facilitating effect of fluoxetine on the
survival of recently generated cells, suggesting that under non
lesion conditions, the BLA restrains the positive effects of the
antidepressant on cell survival (Fig. 4). As a note of caution, it is
important to notice that although in all cases amygdala lesions
included at least 40% of the BLA, in some cases the maximum
extension included adjacent basal and/or medial areas whose
potential role in the present observations cannot be excluded.
Interestingly, these results implicating the involvement of the BLA
on hippocampal cell survival stimulated by fluoxetine, but not
under basal conditions, are reminiscent of the BLA involvement in
the modulation of memory consolidation in other brain regions
(notably the hippocampus) induced by stress and emotions without
affecting memory formation in itself [32,36,70]. A potential role
for the amygdala in these results is supported by several examples
of inhibitory effects of SSRIs on amygdala activity in animals
[19,22] and humans as well [23], although activating effects were
also reported [71], as evidence indicating that enhanced amygdala
activity as induced by seizures associated with rapid electrical
amygdala kindling increases the addition of newly generated
granule cell neurons to the granular cell layer of the dentate gyrus
[72]. Alternatively, the BLA might be exerting a modulatory
influence on the hippocampal milieu that is relevant for fluoxetine-
stimulated cell survival. This concept is linked to the view that the
amygdala is able to affect both the induction of plasticity [73,74]
and meta-plasticity [35] in the dentate gyrus. Translated into the
current framework, amygdala influences on cell survival might be
achieved by BLA modulation of fluoxetine’s molecular and
network targets in the hippocampus.
The stacked model (Fig. 4) revealed a surprising relationship
between anxiety and cell survival that differed upon the lesion
condition: while in Sham animals anxiety levelsnegatively predicted
cell survival, this relationship was positive in BLA lesioned rats.
Given the strong anxiolytic effects induced by BLA lesions, these
results reveal the existence of an inverted-U shape relationship
between anxiety and cell survival, with both low and high extremes
in anxiety being related to lower levels of cell survival than
intermediate levels of anxiety. Although intriguing given its novelty
in the field of neurogenesis, the existence of an inverted-U shape
between emotionality and hippocampal function is not surprising.
There are many examples in the literature for complex effects of
stress on cognition [75,76,77,78,79] and hippocampal plasticity
[80,81] showing similar biphasic relationships. Further studies
should explore to what extent this observation for an inverted-U
shape between anxiety and neurogenesis is applicable to the range
of normal variation in anxiety trait or related, for the lower extreme
of the anxiety spectrum to pathological conditions linked to
amygdala damage.
Asforcellproliferation,ouranalysesincontrastrevealedthatBLA
lesions seem to indirectly influence its rate through their effects in
anxiety: by reducing anxiety levels, which are negatively related to
cell proliferation, BLA lesions seem to have a positive impact in cell
proliferation. In fact, anxiety on its own was a highly predictive
factor of cell proliferation. This finding is in agreement with emerg-
ing evidence supporting a link between anxiety and hippocampal
neurogenesis. Individual differences inrats’ traitanxiety were related
to the negative and positive impact, respectively, of chronic stress
andchronictreatmentwithacorticotrophinreleasingfactorreceptor
1 (CRFR1) antagonist on hippocampal cell proliferation [51].
Transgenic mice, in which hippocampal neurogenesis was specifi-
cally impaired, exhibited a striking increase in anxiety-related
behaviors [43]. It should also be noted that several studies did not
find any impact of inhibiting neurogenesis on anxiety- or depression-
related behaviors [9,82,83,84].
We also found that BLA lesions exerted antidepressive
behavioral effects irrespective of fluoxetine treatment. These
results are in agreement with previous observations showing
attenuated anxiety- and depression-related behaviors following
bilateral BLA lesions in animals [85] and humans [86], while
anxiogenic-like effects after amygdala stimulation through kindling
protocols [87]. Viral-induced increase in the molecular expression
of the transcription factor CREB in the BLA in rats was also
shown to result in changes in anxiety- and depression-like
behaviors [88]. Moreover, anxiety here largely explained (partly
via Ki67, and also via other unspecified factors) differences in
depression-like behavior in vehicle treated animals. Note that
anxiety was evaluated before drug treatment and that anxiety
levels have been reported to be changed by fluoxetine [18,89].
Interestingly, these results are also in line with a large body of
literature in humans indicating close links between high anxiety
trait, depression and the propensity of the amygdala to show
hyperactivation [42].
A specific goal of this study was to explore whether BLA lesions
and anxiety might influence the link from hippocampal cell
proliferation and survival to depression-like behavior, a topic that
has received a great deal of attention in recent years. A view is
emerging that pre-existing anxiety might determine the range of
Amygdala and Neurogenesis
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[9,69,90]. Our SEM analyses suggest that, in relation to the
attenuation of depression-like behavior, reduced BLA output and
low anxiety are critical factors determining the engagement of
newborn cells—differentially affecting proliferative potential and
survival. These findings might help explain existing discrepancies
in the literature with regards to the dependence of behavioral
effects of antidepressants on hippocampal neurogenesis [3]. In
fact, antidepressant-like behavioral effects of chronic fluoxetine
treatment were blocked by ablation of neurogenesis in the low
anxious strain of mice, C57BL/6 [9], but not in the highly anxious
strain BABL/c [91]. Although neurogenesis is frequently found to
be unnecessary for fluoxetine effects in the forced-swim test in
mice [8,91], it was shown to be critical in rats [92], supporting the
specific link observed in our study. However, it is important to
note that a recent study showed that antidepressants (including
fluoxetine) retain their therapeutic efficacy in reducing both
several indices of depression-like behavior (including the forced
swim test) even when neurogenesis is pharmacologically blocked
implicating, instead neuronal remodeling as the mechanism
associated with the antidepressant activity [93].
Anxiety seems to be central to the converging effects of
antidepressant treatment and BLA lesions. It emerged that
modulation of cell proliferation by fluoxetine was particularly
strong with a normally functioning BLA. Critically, the antide-
pressant treatment was found to suppress the inhibitory indirect
effect of the BLA by reducing the impact of anxiety on cell
proliferation (Fig. 6). However, the relationship between anxiety
and neurogenesis is still far from being clearly understood. A
recent report showed that administration of the anxiolytic
diazepam simultaneously to fluoxetine treatment completely
blocked the SSRI-induced increase in both neurogenesis and cell
survival [94].
Taken together, our observations would suggest that the
behavioral effects of antidepressants seem to be antagonized by
a normally functioning BLA. Furthermore, antidepressants and
normal BLA function exert opposite, interacting influences over
cell proliferation and survival that is largely associated with the
resulting impact of anxiety (Fig. 3).
In summary, our study highlights an important role for the
amygdala on fluoxetine-stimulated cell proliferation and survival,
as well as on the establishment of a link between cell proliferation
and depression-like behavior. It also highlights an important role
for anxiety in mediating the effects of basolateral amygdala and
antidepressant activity on cell proliferation and survival. The
application of structural equation modeling in the investigation of
a complex, multidimensional phenomenon allowed us to capture
important contributing factors operating together to determine the
behavioral and neurobiological outcomes of fluoxetine treatment.
Given the multiple targets of antidepressants effects in the brain
[95,96], our study emphasizes the importance of considering
indirect actions involved in their modulatory effects on adult
hippocampal neurogenesis.
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Figure S1 BLA histochemical lesions with NMDA. A. Recon-
struction of the minimal (black) and maximal (gray) extents of
lesion. B. NeuN immunohistochemistry for representative BLA
lesions. C. NeuN immunohistochemistry for representative sham
lesion. Coordinates of the coronal sections are indicated with
reference to Bregma. Plates are adapted from the atlas of Paxinos
and Watson (Paxinos and Watson, 1997).
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Figure S2 Effect of BLA neurochemical lesion on anxiety levels.
Values show the mean + SEM. **p,0.01.
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Figure S3 Levels of anxiety after classification of animals into
the dichotomized categories of low and high anxiety. Values show
the mean + SEM. **p,0.01.
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